143 related articles for article (PubMed ID: 12110344)
1. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer.
Hahn M; Hagedorn G; Kuhlisch E; Schackert HK; Eckelt U
Oral Oncol; 2002 Jul; 38(5):486-90. PubMed ID: 12110344
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma.
Morita S; Yano M; Tsujinaka T; Akiyama Y; Taniguchi M; Kaneko K; Miki H; Fujii T; Yoshino K; Kusuoka H; Monden M
Int J Cancer; 1999 Mar; 80(5):685-8. PubMed ID: 10048967
[TBL] [Abstract][Full Text] [Related]
3. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
5. Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes.
Buch SC; Nazar-Stewart V; Weissfeld JL; Romkes M
Head Neck; 2008 Sep; 30(9):1139-47. PubMed ID: 18642288
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.
Shukla D; Dinesh Kale A; Hallikerimath S; Vivekanandhan S; Venkatakanthaiah Y
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Sep; 156(3):253-9. PubMed ID: 22660220
[TBL] [Abstract][Full Text] [Related]
7. CYP1A1 and GSTM1 polymorphisms and oral cancer risk.
Park JY; Muscat JE; Ren Q; Schantz SP; Harwick RD; Stern JC; Pike V; Richie JP; Lazarus P
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):791-7. PubMed ID: 9332761
[TBL] [Abstract][Full Text] [Related]
8. Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes.
Sato M; Sato T; Izumo T; Amagasa T
Oral Oncol; 2000 May; 36(3):267-71. PubMed ID: 10793329
[TBL] [Abstract][Full Text] [Related]
9. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity.
Gronau S; Koenig-Greger D; Jerg M; Riechelmann H
Oral Dis; 2003 Mar; 9(2):62-7. PubMed ID: 12657030
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer.
Katoh T; Kaneko S; Kohshi K; Munaka M; Kitagawa K; Kunugita N; Ikemura K; Kawamoto T
Int J Cancer; 1999 Nov; 83(5):606-9. PubMed ID: 10521794
[TBL] [Abstract][Full Text] [Related]
12. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro.
Marques CF; Koifman S; Koifman RJ; Boffetta P; Brennan P; Hatagima A
Oral Oncol; 2006 Jul; 42(6):632-7. PubMed ID: 16488179
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose.
Tanimoto K; Hayashi S; Yoshiga K; Ichikawa T
Oral Oncol; 1999 Mar; 35(2):191-6. PubMed ID: 10435155
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer.
Sreelekha TT; Ramadas K; Pandey M; Thomas G; Nalinakumari KR; Pillai MR
Oral Oncol; 2001 Oct; 37(7):593-8. PubMed ID: 11564581
[TBL] [Abstract][Full Text] [Related]
15. [Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population].
Wang N; Wu Y; Zhou X; Wu Y
Wei Sheng Yan Jiu; 2012 Mar; 41(2):251-6. PubMed ID: 22611936
[TBL] [Abstract][Full Text] [Related]
16. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
Suzuki S; Muroishi Y; Nakanishi I; Oda Y
J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
Yoshida K; Osawa K; Kasahara M; Miyaishi A; Nakanishi K; Hayamizu S; Osawa Y; Tsutou A; Tabuchi Y; Shimada E; Tanaka K; Yamamoto M; Takahashi J
Asian Pac J Cancer Prev; 2007; 8(3):438-44. PubMed ID: 18159984
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer.
Cha IH; Park JY; Chung WY; Choi MA; Kim HJ; Park KK
Yonsei Med J; 2007 Apr; 48(2):233-9. PubMed ID: 17461521
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer.
Sato M; Sato T; Izumo T; Amagasa T
Carcinogenesis; 1999 Oct; 20(10):1927-31. PubMed ID: 10506106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
